Asacol Buyers Say Product-Hopping Suit Requires Trial
Buyers of Allergan's ulcerative colitis drugs have told a Massachusetts federal court that they were coerced into paying for higher-priced medication when the company blocked a generic drug from the market,...To view the full article, register now.
Already a subscriber? Click here to view full article